Best Compounded GLP-1 Providers That Accept FSA

Last verified: August 15, 2026 · Research and verification by the Weight Loss Provider Guide editorial team · How we verify providers

Affiliate disclosure: We may earn a commission if you sign up through some links on this page, at no extra cost to you. Rankings are set by verified payment path, documentation support, price, commitment terms, and current regulatory record — not by payout. Several providers that pay us more were moved out of the lead on this page. We'd rather lose the click than send you somewhere your money gets stuck.

The bottom line, first

The best compounded GLP-1 provider that accepts FSA right now is Shed. Its own help center says it accepts HSA and FSA cards for prescription purchases — and then does something no other provider we checked does. It tells you, in writing, which parts of its own program may qualify with a receipt and which parts may need more paperwork. Prescription supplies, provider visits, and shipping are listed as eligible with a receipt. Health coaching and supplements may need added documentation. Shed also publishes the exact path for downloading a detailed receipt.

Shed advertises compounded semaglutide from $159/month and compounded tirzepatide from $239/month, but its live pages show conflicting starting prices. Treat those as floor prices and confirm the exact charge at checkout.

If price matters more than paperwork, go with Embody instead. Its current terms list compounded semaglutide at $79 on the monthly plan and compounded tirzepatide at $129 on the monthly plan. Longer commitments lower the effective monthly price. Embody does not publish a receipt or letter-of-medical-necessity process, so get that answer in writing before paying.

We compared 15 compounded GLP-1 providers and close alternatives that accept FSA cards, support reimbursement, or matter to this decision. Here is the part almost nobody tells you, and it is the reason this page exists:

Your FSA card can decline at a telehealth checkout even when the expense may qualify. That is not a final decision about you or your prescription. It can be a payment-system problem. The usual backup is simple: pay another way, get an itemized receipt, and submit a claim.

Which means the badge on a provider's website is almost never the thing that decides whether your money moves. The receipt is.

We checked 15 services on that basis. Shed won the documentation lane. Embody won the price lane. Seven providers went into a caution lane because FDA issued warning letters about their compounded-drug marketing or labeling. Yucca is disqualified for this exact job by its own FAQ.

Quick picks

Compare all 15 services side by side ↓

How we verified these compounded GLP-1 providers

Before we rank anything, here is the work behind it.

On August 15, 2026 we read: each provider's public pricing, FSA/HSA guidance, help center, terms, cancellation language, and refund language where available. We searched FDA's warning-letter database by provider and parent company. We checked current IRS guidance, FSAFEDS claim-document rules, and benefits-card guidance from HealthEquity.

What we did not do: we did not buy a subscription from every provider with an FSA card, and we did not call every billing team. A provider saying “FSA accepted” is not a promise that your specific plan will approve the charge. Your plan administrator applies your plan's rules.

How we label evidence:

• Provider-stated — the provider publishes it on its own site.
• Primary-source verified — the IRS, FDA, FSAFEDS, or another government source publishes it.
• Not published — we could not find a public policy. The provider may still help, but you must ask.
• Conflicting — the provider's own live pages do not agree.

Not published never counts in a provider's favor. A blank field is a risk, not a neutral.

Next scheduled re-verification: November 2026. Price, checkout, cancellation, and state availability can change before then, so confirm the live total before paying.

What does “accepts FSA” actually mean?

Answer capsule: “Accepts FSA” can mean three different things. It can mean the card works at checkout, that you pay with a personal card and file for reimbursement, or that the card works now and your plan asks for proof later. An FSA is employer-sponsored pre-tax money for eligible health expenses. The provider can describe its payment process, but your plan administrator applies your plan's claim rules.

Most pages give you a green checkmark. That checkmark hides three very different experiences.

Path 1: The card works at checkout

You type in your FSA card. It goes through.

That is convenient. It is not always final. Benefits-card administrators can still ask you to verify the charge with an itemized receipt or other records. If you do not answer, your plan may suspend the card and require the charge to be corrected.

Path 2: You pay yourself, then get reimbursed

You use your regular debit or credit card. You save the itemized receipt. You upload it to your FSA portal. If the claim is approved, your plan reimburses you from your FSA balance.

You still use pre-tax FSA dollars. The tradeoff is that you must cover the charge until your plan processes the claim. Processing time varies by administrator.

This path works only if your provider gives you documentation worth submitting. Some do. Some do not.

Path 3: The card works, then the plan asks for proof

This is the one that catches people off guard. You paid earlier. Then an email arrives asking for an itemized receipt, prescription, letter of medical necessity, or other proof by a deadline.

The deadline and consequences come from your plan, not from a universal 106-day or 200-day rule. Read the notice and answer it before the listed date.

The one sentence to remember

A decline is not a denial. And a swipe is not an approval.

Both are payment events. Neither one, by itself, is your plan's final eligibility decision.

That is why we do not rank providers only on whether they say they take FSA. We rank them on whether they can help you finish the job.

Which compounded GLP-1 providers accept FSA? The full audit

Answer capsule: Shed, Embody, Willow, IVY RX, Direct Meds, Ivim, MEDVi, SkinnyRX, Eden, and Maximus state that HSA or FSA cards can be used. Patiently is sold through FSA Store but still says eligibility varies by plan. MyStart says some cards work and publishes a reimbursement packet. Hers recommends paying with a regular card and downloading a receipt. Ro does not accept HSA/FSA cards but provides a detailed receipt. Shed has the strongest public documentation. Yucca says it does not provide itemized receipts or letters of medical necessity.

Here is the whole thing in one table. Sort it, scan it, screenshot it.

How to read this table. “Provider-stated” means the company publishes the claim. “Not published” means we could not find a public policy. The provider may still help, but you must ask before paying. “No provider-specific letter located” means our FDA search did not find one through August 15, 2026. It is not a promise that no other complaint, state action, pharmacy action, or later letter exists.

A warning letter is an FDA allegation about marketing or labeling. It is not a recall, fine, criminal charge, or proof that an individual patient's prescription was unsafe. We explain the letters further down.

The friction score is out of 100 and measures the public evidence that you can complete an FSA payment or reimbursement without a paperwork surprise. It is not a safety score, medical-quality score, or effectiveness rating. The formula is published in How we ranked these providers. Missing information scores zero.

Prices are the public amounts we could verify on August 15, 2026. Some are promotional floors, some require prepayment, and some provider pages conflict. The amount shown at your checkout controls.

→ See Shed's current plans and FSA checkout options

We may earn a commission if you enroll through this link. It does not change your price.

Which provider fits your specific situation?

Answer capsule: The right provider depends less on the FSA logo and more on four things: how strict your plan is about documents, what is due today, how long you must commit, and whether the expense date fits inside your plan year. Strict plans need a provider with a published receipt path. Late-year buyers should favor a true monthly option unless their administrator confirms how a prepay will be handled.

Find yourself in this list.

Your administrator has asked you to prove a charge before → Shed. You need a provider that has already thought about this. Shed publishes its receipt path and tells you which parts of its program may need more proof.

You want the cheapest current monthly option → Embody. Its current terms list $79 for monthly compounded semaglutide and $129 for monthly compounded tirzepatide. Ask for the receipt format before you pay.

It is late in your plan year and you are worried about stranding money → Embody's monthly plan. A monthly option avoids locking you into later deliveries. Your administrator still decides when each expense is incurred. See the timing math.

You want to see “FSA at checkout” in black and white → Willow. It says HSA/FSA payment is accepted at checkout. The price starts at $299 and can change with the plan or dose.

You can pay $1,164 today and want an instant itemized receipt → IVY RX. That $97 monthly figure is an annual price divided by twelve, not a monthly charge.

You want a ready-made document packet and accept a regulatory caution → MyStart. It publishes an invoice/provider/prescription packet, but FDA issued it a warning letter in September 2025.

You want a needle-free option → Shed, Willow, and Direct Meds advertise oral or sublingual compounded formats. Those products are not FDA-approved, and the evidence for a compounded oral format is not automatically the same as the evidence for an FDA-approved drug or an injected compounded product. Ask exactly what drug, form, dose, and pharmacy you would receive.

You want FDA-approved medication or want to use insurance → you are on the wrong page. We will point you to the right lane. No hard feelings.

Your plan has never asked you for anything → honestly, price may be your main variable. Embody is the current price leader. Keep every receipt anyway.

Why Shed is our top pick for FSA users

Answer capsule: Shed is the strongest compounded GLP-1 provider for FSA users because its public FSA guidance is more specific than any competitor's we found. It says it accepts HSA and FSA cards for prescription purchases, describes which program charges may qualify with a receipt, and publishes the member-portal path for downloading a detailed receipt. It advertises compounded semaglutide from $159/month and compounded tirzepatide from $239/month, although its live pages show conflicting price blocks.

Let us be specific about what makes this different, because “they have good documentation” is a useless sentence.

The line-item split nobody else publishes

Most compounded providers we checked say some version of “HSA/FSA accepted, check with your administrator.” That is a shrug in a nice font.

Shed's help center breaks its own program apart. It lists prescription supplies, provider visits, and shipping as expenses that may qualify with a receipt. It says health coaching and supplements may require added documentation.

Read that again, because it is doing something important. Shed is telling you, before you pay, which parts of a bundled program are stronger and which parts may get questioned. That is the most useful public FSA guidance we found on a compounded-provider site.

Why does it matter? Because when your administrator reviews a charge, it looks at the description and supporting records. “Weight loss program” is vague. A receipt that identifies prescription supplies, clinical care, shipping, coaching, and supplements gives the reviewer something concrete to evaluate.

The receipt path, spelled out

Shed publishes the actual path to get your receipt:

1. Open the Shed Member Portal.
2. Log in.
3. Open the My Plan tab.
4. Find the payment under Payment History.
5. Select the download icon beside that payment.

Five listed actions. Published. On the record.

Compare that with emailing support and hoping.

Shed also says to reach out if a letter of medical necessity or added documentation is required. That is not a promise that a clinician will issue an LMN. We give it partial credit, not full credit.

What you can actually get

Shed currently advertises:

• Compounded semaglutide injection — from $159/month on one live price block
• Compounded tirzepatide injection — from $239/month on one live price block
• Provider-stated oral or sublingual compounded formats — including drops or lozenges on some pages
• Microdose options — if prescribed
• FDA-approved options too — including Wegovy®, Zepbound®, and Foundayo™
• A fully online intake, visit, payment, and member portal

Foundayo is orforglipron, an FDA-approved daily oral GLP-1. It is not semaglutide and it is not an injection.

That format range matters if needles are your sticking point. But do not treat every format as interchangeable. Ask the exact active ingredient, route, concentration, pharmacy, price, and evidence for the form you are offered.

The honest tradeoff

Here it is, straight.

Shed is not the cheapest, and its own live pages do not show one clean price. One current landing page displays semaglutide from $159 and tirzepatide from $239, then repeats higher $175 and $245 figures lower on the same page. Other Shed pages show still different amounts. The only honest move is to treat the lowest figure as an advertised floor and use the checkout total as the real price.

Shed's public terms also describe a two-month minimum, cancellation at least 72 hours before the next billing date, and payments that are generally nonrefundable after they are charged.

If the lowest possible monthly price is what you need, Embody starts at $79 for monthly semaglutide and $129 for monthly tirzepatide under its current terms. Go there instead.

On this page, documentation is the whole ballgame. A cheap program with a receipt your plan cannot use can cost more than a higher-priced program with a clean paper trail. You are not buying only a monthly price. You are buying a monthly price you can document.

Who Shed is right for

• Your plan has questioned a charge before
• You want a receipt you can download yourself
• You want the provider's FSA guidance in writing
• You can live with a two-month minimum
• You want to compare injection and needle-free formats with a clinician

Who should skip Shed

• Lowest price is your top priority → Embody
• You want no minimum at all → use Embody's monthly plan or compare Willow's monthly subscription
• You want FDA-approved medication only → Ro or Sesame
• You want one perfectly clear public price → Shed's current pages do not give you that

Does that sound like your situation? → Check Shed's live checkout total and FSA options

Is Embody the best low-cost option for FSA?

Answer capsule: Embody is the lowest-priced current monthly compounded GLP-1 program we verified that states HSA/FSA cards can be used. Its terms effective July 1, 2026 list compounded semaglutide at $79 on the monthly plan and compounded tirzepatide at $129 on the monthly plan. Longer commitments lower the effective price to $69 and $119 per month. Embody does not publish an itemized-receipt or letter-of-medical-necessity process, so FSA users should confirm both in writing before paying.

Embody is the price winner, and it is not close.

What you get

Under Embody's current terms:

• Compounded semaglutide injection — $79 on the monthly plan
• Compounded tirzepatide injection — $129 on the monthly plan
• Semaglutide commitment rates — $76/month for 3 months, $73/month for 6 months, or $69/month for 12 months
• Tirzepatide commitment rates — $126/month for 3 months, $123/month for 6 months, or $119/month for 12 months
• No separate membership fee listed for these plans
• Shipping included
• Named pharmacy partners
• Online clinical review and ongoing messaging

The old Embody terms with a $99 introductory month, $299 refills, and compounded gum plans are no longer active. Do not budget from an old review or screenshot.

A 503A pharmacy prepares patient-specific medication from a valid prescription when the conditions in federal and state law are met. Naming pharmacy partners publicly gives you a name you can check with your state board of pharmacy. It does not make the finished compounded drug FDA-approved.

The monthly advantage nobody prices in

This is the part other comparison pages miss.

Embody gives you a real monthly option. That matters when you are late in your FSA plan year, unsure how long you will stay, or unwilling to prepay several months before you know how your body responds.

But do not turn that into a claim the plan cannot support. Embody is not “no commitment” across every price. The $79 semaglutide and $129 tirzepatide prices are the monthly options. The lower $69 and $119 effective rates require a 12-month commitment.

If your FSA deadline is close, choose the monthly option unless your administrator confirms how it will treat a longer commitment and later shipments.

The old $299 refill math is gone — but read the term

Straight talk on the price. Older comparison pages used a “$79 first month, then $299” structure based on old Embody terms. Embody's terms effective July 1, 2026 say those old plans are no longer active.

Here is the current sticker-price math:

Those totals are far below the 2026 health FSA contribution cap of $3,400. That does not mean a plan must reimburse a full annual commitment on the payment date. Expense timing and documentation still follow your plan's rules.

One thing we are telling you because you should hear it from us

Embody identifies OpenLoop Health as part of its clinical-care network. Other telehealth brands also use outside medical groups and pharmacy partners. That does not mean the brands are the same company, and it does not make a warning letter issued to one brand a warning letter against another.

What it does mean is that the brand on the landing page may not be the clinician group or pharmacy on your records. Before you pay, ask for all three names:

1. The telehealth company taking payment
2. The medical group providing care
3. The pharmacy that may fill the prescription

That answer makes license checks, receipt requests, and billing disputes much easier later.

Who Embody is right for

• Starting price is your main constraint
• You want a true monthly option
• You are late in your plan year and do not want a long prepay
• You are comfortable asking for receipt details before checkout
• You want the pharmacy partners named publicly

Who should skip Embody

• Your plan regularly asks for itemized receipts → Shed publishes its receipt path
• You want FDA-approved medication → Ro
• You want an itemized receipt policy on the public site → IVY RX, MyStart, Hers, or Shed publishes more
• You want the lowest advertised rate without a long term → use the $79 or $129 monthly option, not the annual headline

What to ask before you pay

Send this one sentence through support:

“If I pay with my FSA card or submit for reimbursement, can you give me an itemized receipt showing my name, provider, date, prescription or service description, and amount, and can my treating clinician provide an LMN if my plan requires one?”

Save the written answer.

→ See Embody's live plan total, then get the receipt answer in writing

That CTA says what it says on purpose. Embody is the value pick. Just get the paperwork answer before checkout — it takes one message.

The other providers worth comparing

Answer capsule: Willow, IVY RX, Direct Meds, and Patiently each solve a different part of the FSA problem. Willow publishes the clearest FSA-at-checkout statement but says pricing varies by plan and dose. IVY RX sends an itemized receipt immediately, but its $97 figure requires $1,164 up front. Direct Meds says it accepts HSA/FSA and can provide documents, yet its own pages conflict on price and plan structure. Patiently is built inside FSA Store and starts at $199/month, but still says eligibility varies by plan.

Willow — clearest checkout language

Willow states in its own FAQ that you can use an HSA or FSA to pay for prescriptions at checkout.

Compounded semaglutide starts at $299/month. Compounded tirzepatide starts at $399/month. Willow also says medication costs vary by dosage and prescription. The old claim that Willow holds one flat price at every dose cannot stay.

Its public cancellation language is clear in one place and inconsistent across documents in another. The FAQ says to send the request at least two business days before the next processing date and says a full refund is available if the prescription has not been sent to the pharmacy. Other Willow terms have used two calendar days or a shorter cutoff.

Use the earliest cutoff and get it in writing. A policy conflict is not where you want to test your luck with a prescription charge.

What is missing: we could not find a formal public policy promising an itemized receipt or LMN. Ask before you pay.

→ Check Willow's live price and cancellation cutoff

IVY RX — instant receipt, biggest up-front bill

IVY RX advertises a $97 monthly effective rate on a 12-month semaglutide plan. Read that carefully: the number comes from paying $1,164 at once.

It says its GLP-1 therapy is HSA/FSA eligible and that it sends an itemized receipt immediately. That is genuinely good.

The honest math: $97 is not the charge hitting your card each month. It is an annual charge divided by twelve. Other IVY RX pages also show different starting prices for shorter structures, so compare the total due today — not only the monthly-looking number.

IVY RX is no longer the lowest yearly cost in this audit. Embody's current annual semaglutide commitment is $828. IVY RX's advantage is the immediate receipt, not the lowest annual total.

IVY RX makes the cleanest timing sense near the start of a plan year, after your administrator confirms how it handles an annual medication plan. Late in a plan year, the up-front structure creates more timing questions.

→ See IVY RX's up-front total and instant-receipt policy

Direct Meds — good documentation, price and plan language that do not line up

Direct Meds says it accepts HSA/FSA payments for GLP-1 treatment and can provide receipts and documentation after approval.

Its current how-it-works page lists plans from $249/month for sublingual semaglutide and $297/month for injections. A current tirzepatide page lists $399/month. Other pages and snippets have shown different figures.

The structure is also muddy. One page says “no subscriptions,” while the same page discusses monthly rates and 6- or 12-month bulk pricing.

We are not going to turn that into one clean comparison-table promise. Get these four items from checkout in writing: the exact drug, form, amount due today, and quantity or months supplied.

Direct Meds is a reasonable comparison because the documentation path is public. It is not a lead pick because the pricing and plan language make the commitment harder to understand than it should be.

Patiently, via FSA Store — the FSA-native option

We are including this one even though it does not pay us anything, because leaving it out would make this page less useful.

FSA Store sells a GLP-1 program called Patiently with plans from $199/month. The page is built around using pre-tax health-account money, and the checkout sits inside a retailer people already use for FSA purchases.

Its own terms still say eligibility varies by plan. That is honest and consistent with the rest of this guide.

What we could not confirm publicly: the exact receipt format, whether an LMN is available, exact medication-by-medication pricing, and which pharmacy may fill the prescription. Ask before you commit.

Which providers should FSA users approach with caution?

Answer capsule: Seven services in this audit received FDA warning letters between September 2025 and June 2026 over compounded-drug marketing or labeling. A warning letter is a formal notice of FDA's concerns and an opportunity for the company to respond. It is not a recall, fine, criminal charge, or proof that an individual patient's prescription was unsafe. On a page about where to spend pre-tax medical dollars, a recent letter moves a provider out of the lead. It does not tell a current patient to stop treatment.

We are naming these with dates and letter numbers, because red icons with no explanation help nobody.

The register

FDA announced a 30-letter telehealth enforcement wave on March 3, 2026. It later posted another group of letters issued June 8, including Eden and Maximus.

What a warning letter is — and is not

It is: a formal public notice that FDA believes identified marketing, labeling, or conduct violates federal law. The letters above generally gave the recipients 15 working or business days to respond and describe corrective steps.

It is not: a recall, a fine, a criminal charge, a final court judgment, or a finding that any one patient's prescription was unsafe.

The recurring issue was not “telehealth exists.” It was how compounded products were described: using a telehealth brand on imagery in a way FDA said implied it was the compounder, calling pharmacies “FDA approved” or “FDA licensed,” or suggesting a compounded product was generic, the same as, or clinically proven like an FDA-approved drug.

If you are already a patient at one of these companies, nothing on this page tells you to stop. Talk to your prescriber about your care. But if you are choosing fresh, we put providers with cleaner public records and clearer documents first.

The document-strong caution: MyStart

MyStart deserves a specific note because its FSA paperwork is stronger than most of the lead group.

It says some HSA/FSA cards work directly. When they do not, it provides a documentation packet with an itemized invoice, provider information, prescription details, and proof of payment. That is exactly the kind of packet a strict plan may want.

But FDA warning letter #714755 alleged that MyStart used “Generic Ozempic” and same-ingredient/results claims for compounded semaglutide. Good paperwork does not erase a regulatory letter. The letter does not erase the good paperwork either. That is why MyStart scores well for friction and still stays in caution.

The one provider we are excluding outright

Yucca Health. Its own FAQ says many patients use HSA or FSA funds, but Yucca does not provide itemized receipts or letters of medical necessity.

On another comparison page, that might be a footnote. On this page, it is disqualifying. Those are common documents a plan may request when a weight-management charge is not clear.

Yucca may have a low price and happy customers. It is structurally wrong for this specific job. If your FSA plan has ever asked you to substantiate anything, Yucca has already told you it will not provide the two documents most likely to solve the problem. Go to Shed instead.

Why did my FSA card decline for a GLP-1?

Answer capsule: An FSA card decline at a telehealth checkout can reflect merchant coding, card settings, account limits, or missing automatic substantiation — not a final ruling that the prescription is ineligible. HealthEquity tells members to pay another way and submit an itemized receipt when a card declines. An accepted card charge can still be reviewed later. The practical fix is to save the documents and use the reimbursement path.

This is the section we wish had existed when we started researching this.

Why the pharmacy counter may work when a website does not

Some pharmacies and retailers use an Inventory Information Approval System, or IIAS. It can verify eligible retail health items at the point of sale. Medical merchants may also be recognized through merchant coding.

A telehealth checkout may be coded or configured differently. The card system may see a merchant and an amount without enough information to confirm what was purchased. That can trigger a decline even when the underlying expense may qualify under the plan.

That is why HealthEquity's own guidance says that if an FSA card declines, you can pay another way and submit an itemized receipt and documentation for reimbursement.

The part specific to GLP-1 programs

A GLP-1 program may bundle several things into one charge:

• Prescription medication
• A provider review or follow-up visit
• Coaching
• Supplements
• Shipping
• App or membership access

The payment system does not necessarily see those line items. It may see only one merchant and one total.

That is what makes a split receipt useful. If the plan needs to evaluate medication, clinical care, coaching, and supplements differently, one vague “weight loss program” line gives it very little to work with.

Which brings us back to the point of this whole page: the receipt is what lets the plan review the real expense.

The four real causes, in the order to check them

1. Balance, expiration, or card limit. Log in to your FSA portal and check the available amount, card status, and any transaction limit.
2. Merchant coding or checkout setup. The provider may accept FSA reimbursement without having a card setup that approves every direct swipe.
3. A mixed or vague charge. Medication, care, coaching, supplements, and shipping may be bundled under one description.
4. A plan flag. Your administrator may require documents before or after it allows the charge.

What to do now

1. Take a screenshot of the decline.
2. Ask the provider for an itemized receipt and the exact charge description before trying again.
3. Pay with a regular card only when you are comfortable floating the cost.
4. Submit the itemized receipt, prescription, and any requested LMN through your FSA portal.
5. Save the claim number and response.

You can still receive the same FSA tax treatment if the claim is approved. The difference is that reimbursement happens after review instead of at checkout. Timing varies by plan.

That is it. A bounced card is not a wall. It is a signal to move from the card lane to the document lane.

→ See Shed's plans — the receipt path is published before you buy

What does my plan administrator actually want to see?

Answer capsule: Many FSA administrators want an itemized receipt showing five core facts: patient, provider or merchant, date of service or purchase, type of service or product, and cost. FSAFEDS publishes those five fields and says a credit-card receipt or canceled check usually is not enough. Your plan may also request a prescription, LMN, diagnosis documentation, or proof of payment.

Benefits teams sometimes call this the Rule of Five. It is a useful shorthand, not a claim that every employer plan uses one identical form.

The five core receipt fields

1. Patient name — the person who received the care or item
2. Provider or merchant name
3. Date of service or purchase
4. Type of service or product — a useful description, not only “program”
5. Out-of-pocket cost

Miss one and the claim can bounce. FSAFEDS says credit-card slips, canceled checks, and balance-forward statements usually do not include enough information.

Why “description” is the field that kills claims

A receipt that says only “weight loss program” does not tell a reviewer whether the charge was for a prescription, a clinical visit, coaching, supplements, or a general-wellness service.

That does not prove the expense is ineligible. It means the document is weak.

The fix is concrete: ask the provider to identify the prescription or clinical service, the patient, the date, the provider, and the amount. Do not invent wording yourself. The provider must issue the record.

The advice everyone gets backwards

Here is where we disagree with a lot of comparison pages, including one of our own that this guide corrects.

Conventional wisdom: one bundled price makes FSA paperwork simpler.

Our conclusion: a detailed receipt is safer when the plan reviews different parts of the bundle differently.

A vague bundled receipt says: “Monthly weight management program — $299.” The reviewer has to decide what that whole line means.

A split receipt might say: “Prescription medication — $224. Clinical services — $75.” Now the reviewer can see what was provided. If it asks about one line, the other line is not hidden inside the same vague description.

That does not guarantee partial approval. It gives the plan better evidence.

The rule: the more your plan asks for paperwork, the more you want a provider that identifies the parts of the bill.

This is why Shed's published eligible/added-document split earns the top spot. It pulls the program apart before you pay.

Do you need a letter of medical necessity?

A letter of medical necessity, or LMN, is a signed statement from a treating clinician explaining why a product or service is needed to treat a diagnosed condition.

You may not need one for every prescription claim. Weight-management programs and vague bundled charges are more likely to trigger the request. Ask your administrator before buying instead of guessing.

A useful LMN commonly includes:

• Your name
• The diagnosed condition
• The treatment or service being recommended
• Why the treatment is medically necessary rather than general wellness or appearance spending
• The expected treatment period, when relevant
• The clinician's name, credentials, signature, and date

Your plan may ask for more or less.

Two important limits. First, the treating clinician must write or approve the LMN. You cannot issue one to yourself. Second, an LMN supports the medical purpose of an expense. It does not turn an unlawful drug purchase or a general-wellness expense into a qualified medical expense.

📄 Download the FSA Document Request Checklist — one printable page with the five receipt fields and copy-paste requests for an itemized receipt and LMN. No email required.

How many months of GLP-1 will my FSA actually buy?

Answer capsule: The 2026 health FSA salary-reduction limit is $3,400, and an employer plan that permits carryover can allow up to $680 into the next plan year. But the practical limit is your balance, your plan deadline, each service or dispensing date, and the number of charges that occur before that deadline. Starting a $299 monthly program in mid-August on a calendar-year plan creates about four to five charge or service dates before December 31 — roughly $1,196 to $1,495, not $3,400.

This is the math nobody runs, and it changes what you should do.

The 2026 numbers

• Health FSA salary-reduction cap: $3,400
• Maximum carryover from a 2026 plan year: $680, if your employer's plan offers carryover
• HSA cap for comparison: $4,400 self-only and $8,750 family
• HSA money: stays in the account until you use it

Sources: IRS Revenue Procedure 2025-32 and the IRS 2026 HSA-limit announcement.

Check your own plan year before you do anything with these numbers. Calendar-year plans are common, not universal. Carryover and grace-period rules depend on the employer plan. Log in and find your real deadline. We are not going to invent urgency you may not have.

The arithmetic, if your plan year ends December 31

From August 15 through December 31, a monthly program usually creates about four to five billing or service dates, depending on the first date and schedule.

Here is what that means. If you are sitting on a full unspent $3,400 on August 15, a normal monthly GLP-1 program may not use the full balance before a December 31 deadline. At $299/month, four to five cycles total about $1,196 to $1,495.

The rest needs another eligible use, an allowed carryover, or it may be forfeited under your plan.

Why prepaying to “use it up” can backfire

The obvious move is to buy a six- or twelve-month plan late in the year and spend the balance at once.

Do not do that until your administrator explains how it treats the expense. FSAFEDS requires service dates, not only a payment date, and its claim form asks you to certify that you already received the products or services. A prescription plan that sends medication in later shipments may create later expense dates even when you paid earlier.

IRS Publication 502 also discusses future medical care, but Publication 502 is written for the medical-expense deduction and expressly says that its timing rule is not itself the rule for deciding FSA reimbursement. Your FSA plan document controls.

The safe question is:

“If I prepay this plan today and medication is dispensed or services are provided over later months, on what date does our plan treat each part as incurred?”

Get the answer in writing before using a large FSA balance.

What to actually do

1. Check your real plan-year deadline and carryover rule.
2. Choose monthly billing when timing is uncertain.
3. Ask how the plan treats prepaid medication and later shipments.
4. Use the rest on other eligible expenses you can incur before the deadline — such as copays, dental care, glasses, first-aid supplies, or eligible sunscreen.
5. Do not use the FSA only because the card accepts the charge. Keep documents for every cycle.

Which programs fit under the $3,400 annual contribution cap on sticker price?

This table compares public sticker prices. It does not promise that a plan will reimburse a full annual prepay in one plan year.

🧮 Run your own numbers with the FSA Reality Calculator →

Enter your balance, deadline, first charge date, monthly price, and plan length. It shows the charge dates that fit before the deadline, the balance left over, and whether a commitment runs past your plan year.

It runs in your browser. Nothing is stored or sent.

→ Compare Embody's monthly option — useful when your deadline is close

Can you use FSA for compounded semaglutide or tirzepatide?

Answer capsule: Often, yes — when a licensed clinician prescribes the medication to treat a specific diagnosed disease and the expense meets your plan's rules. IRS guidance says a weight-loss program can qualify when it treats a disease such as obesity, diabetes, hypertension, or heart disease. Prescribed medicines are qualified medical expenses under the federal tax rules. Compounded status does not automatically disqualify the expense, but an FSA card swipe is not a guarantee and your administrator can require documentation.

Two things need to be true.

One: a licensed clinician prescribed it. An over-the-counter supplement marketed as “GLP-1 support” is not the same thing as a prescribed drug.

Two: the expense is for medical treatment of a diagnosed condition — not only appearance, general wellness, or a desire to lose a few pounds without a medical diagnosis.

That is the rule. Notice what is not the deciding test: whether the finished product is FDA-approved.

The word that matters for the tax rule is “prescribed”

IRS Publication 502 defines a prescribed drug as one that requires a doctor's prescription for use by an individual. The IRS weight-loss FAQ says programs can qualify when they treat a specific disease diagnosed by a physician.

So compounded status does not automatically block FSA eligibility. It does create a separate safety and regulatory question, and your plan may ask for more records when the charge description is vague.

One rule that can disqualify it entirely

IRS guidance excludes illegal treatments even when a practitioner recommends them. It also limits foreign-drug expenses to drugs imported legally or purchased and used legally in another country.

Translation: a prescription does not rescue an unlawful purchase.

Overseas “research peptides,” products sold without a valid prescription, or a seller that will not identify a licensed U.S. pharmacy are not the same as patient-specific medication prescribed through a licensed clinician and dispensed by a licensed pharmacy.

Does FSA cover the membership fee, or only the medication?

The prescription medication is the strongest and clearest part of the claim when it treats a diagnosed condition.

A clinical visit, prescription-management fee, or medically necessary weight-management program may also qualify. A general wellness membership, supplements, or coaching without a medical-treatment connection may need more proof or may not qualify.

The risk is not only the fee. It is a bundled bill that does not show the plan what each part was. Ask for a split or detailed receipt.

Are compounded GLP-1 medications FDA-approved?

Answer capsule: No. Compounded GLP-1 medications are not FDA-approved. FDA does not review a finished compounded drug for safety, effectiveness, or quality before it is marketed, and a compounded drug is not an FDA-approved generic. Compounding can be lawful when the applicable federal and state conditions are met, but it follows a different regulatory path from Wegovy, Zepbound, or Foundayo.

We have to be precise here, and so should any company selling you something.

What “not FDA-approved” means: the pharmacy may be licensed and the prescription may be lawful. FDA still has not approved that finished compounded product the way it approves a new or generic drug.

What it does not mean: every compounded prescription is automatically illegal or unsafe. It means you and the prescriber need a real patient-specific reason, a lawful compounding path, clear pharmacy identification, and correct dosing instructions.

Where things stand as of August 15, 2026

FDA declared the tirzepatide shortage resolved in late 2024 and the semaglutide injection shortage resolved in February 2025. The broad shortage-era copying lane is over.

Federal law still allows patient-specific compounding under section 503A when the statutory conditions are met, but it restricts regular copies of commercially available approved drugs. Section 503B outsourcing facilities follow a different set of conditions.

On April 30, 2026, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list. The comment deadline was extended to July 30, 2026. As of August 15, 2026, FDA had not announced a final decision.

That proposal concerns when registered 503B outsourcing facilities may use those bulk substances. It is not a one-sentence ban on every patient-specific 503A prescription.

Warning signs in marketing

Slow down when a company describes a compounded product as:

• “Generic Ozempic” or “generic Wegovy”
• “The same as” an FDA-approved drug
• Made by an “FDA-approved” or “FDA-licensed” pharmacy
• “Clinically proven” as though the finished compounded product went through FDA review
• FDA-approved

Those are the kinds of claims FDA cited in the warning letters on this page.

Questions to ask about any compounded injection

FDA has reported dosing errors with compounded semaglutide, including errors tied to different concentrations and confusion between milligrams, milliliters, and syringe units. Some cases required hospital care.

Before the first dose, get clear on:

• The exact drug name and concentration
• The prescribed dose in milligrams
• The matching volume or syringe units
• The pharmacy that filled it
• Storage instructions and what to do if the package arrives warm
• Who to call before injecting if the label and instructions do not match

If the syringe markings and your instructions do not line up, stop and call. Do not guess.

An FSA card working is not a safety signal

Worth saying plainly. A card approval means a payment processed. It does not mean FDA approved the product, your plan reviewed the product's quality, the pharmacy license is current, or the treatment is right for you.

Those are separate questions.

If you would rather have FDA-approved medication

Then this page is not your page, and that is fine. Here is where to go.

Ro is the strongest FDA-approved path in this comparison. Its care membership is $39 for the first month, then $149 on the monthly plan or as low as $74/month when an annual plan is prepaid. Medication is extra. Ro offers access to FDA-approved options including Wegovy®, Zepbound®, and Foundayo™ when prescribed, plus insurance-support and prior-authorization help.

Foundayo contains orforglipron, not semaglutide. FDA approved it for chronic weight management on April 1, 2026.

One FSA-specific note: Ro's FAQ says it does not accept HSA/FSA cards, but it provides a detailed receipt after purchase for reimbursement. Given how often documentation matters more than the first swipe, that is a smaller drawback than it sounds.

Sesame Care is the backup. Its care program starts as low as $59/month on an annual structure, medication costs are separate, and it says most subscription services may be eligible for reimbursement. Sesame provides an itemized bill on request.

And if insurance may cover the drug, check that first. Insurance plus FSA reimbursement of a copay can beat a full cash-pay program.

→ Compare FDA-approved GLP-1 options and insurance support

What should I check before paying with my FSA?

Answer capsule: Before paying, get eight answers from the provider: whether an FSA card works, whether reimbursement is supported, what the receipt contains, whether the treating clinician can provide an LMN, whether that document costs extra, the exact charge today, the cancellation cutoff, and the pharmacy that may fill the prescription. Then ask your plan what documents it requires and when it treats the expense as incurred.

Copy and paste these. Seriously — the answers are worth more than any comparison table.

Eight questions for the provider

1. Can I use a health FSA debit card directly at checkout?
2. If the card declines, can I pay with a personal card and get a reimbursement-ready itemized receipt?
3. Will the receipt show the patient, provider or merchant, date, prescription or service description, and amount?
4. Can my treating clinician provide a letter of medical necessity if my plan asks for one?
5. Is there a charge for that letter or corrected receipt?
6. What exact amount will be charged today, what does it cover, and when is the next charge?
7. What is the last moment I can cancel before the order is sent to the pharmacy or the next charge becomes nonrefundable?
8. Which medical group and pharmacy may handle my care and prescription?

Five questions for your plan administrator

1. Does my FSA reimburse prescribed weight-management medication or a medically necessary weight-management program for my diagnosed condition?
2. Do you require an itemized receipt, prescription, LMN, diagnosis documentation, or proof of payment?
3. Can I pay with a personal card and submit for reimbursement if the FSA card declines?
4. What is my plan-year end date, run-out deadline, carryover amount, and grace-period rule?
5. If I prepay several months but medication is dispensed or services are provided later, when does the plan treat each expense as incurred?

That last question is one of the most valuable questions on this page. People assume the card-charge date controls everything. Your plan may use the service or dispensing date instead.

Save these files

• Provider's written answer
• Administrator's written answer
• Prescription
• Itemized receipt
• LMN, if required
• Terms and price screenshot
• Order confirmation
• Pharmacy label
• Claim and appeal numbers

Put them in one folder. You may need them again for a later refill or next plan year.

What if my FSA claim gets denied?

Answer capsule: A denied FSA claim can come from missing or vague documentation, a plan-specific eligibility rule, an expense date outside the plan year, or a charge the plan does not treat as medical care. Get the exact denial reason before doing anything else. Then request the missing record, correct the receipt, add an LMN if requested, and resubmit or appeal by the deadline in your plan documents.

Seven steps. Many document problems are fixed by step three.

1. Save the denial notice. The reason code and deadline control what happens next.

2. Ask exactly what is missing or disputed. Make the administrator name it: patient name, provider, service date, description, amount, prescription, LMN, diagnosis support, proof of payment, or expense timing.

3. Request a corrected itemized receipt. Ask the provider to identify the real prescription or clinical service instead of only “program.” Do not edit the receipt yourself.

4. Request an LMN if the plan asked for one. Your treating clinician writes it. You request it.

5. Resubmit with a cover page listing the claim number, patient, expense date, amount, denial reason, and documents attached.

6. Use the formal appeal process if the claim is still denied and you believe the plan applied its rules incorrectly. Follow the deadline and submission method in your plan documents.

7. Get the resolution in writing. A phone promise is not a record.

The consequence worth knowing about

When a card charge remains unsubstantiated, a plan may suspend the card and require repayment or another correction under the plan's procedures.

That is not a scare tactic. It is why the receipt question belongs before you pay, not after.

📄 Download the FSA Claim Rescue Packet — document checklist, corrected-receipt request, LMN request, administrator call script, and appeal cover page.

How do I check that a provider and pharmacy are legitimate?

Answer capsule: Verify the telehealth company, clinician, medical group, and pharmacy as separate entities. Confirm that the clinician can treat patients in your state and that the pharmacy is licensed by your state board of pharmacy and allowed to ship there. A polished website, FSA badge, registration statement, or low price proves none of that by itself.

Four separate checks

The telehealth company: legal business name, support contact, terms, cancellation policy, and the name that will appear on your card.

The clinician and medical group: clinician name, state license, whether the clinician can treat you in your state, and who handles follow-up questions or side effects.

The pharmacy: legal name, state-board license, authority to ship to your state, physical address and phone, and recent public disciplinary records.

The package: the pharmacy on the label should match the pharmacy the provider told you might fill the prescription. If it does not, call before using the medication.

503A vs. 503B, in plain English

• A 503A pharmacy generally compounds a patient-specific medication based on a valid prescription and must meet the conditions in section 503A and state law.
• A 503B outsourcing facility can compound larger batches under a different federal framework and registers with FDA.

Neither label means the finished compounded drug is FDA-approved. FDA registration is not FDA approval or FDA licensure of the facility or product. FDA made that point directly in the 2026 Eden and Maximus warning letters.

Providers that name pharmacy partners publicly — including Embody and MEDVi on the pages we checked — give you something you can verify. Providers that will not identify the possible pharmacy before payment are asking for more trust.

→ How to verify a compounding pharmacy license before buying

How we ranked these providers

Answer capsule: Providers were scored out of 100 on seven factors weighted toward FSA usability: payment-path clarity, receipt support, LMN support, price and commitment clarity, cancellation and refund clarity, pharmacy disclosure, and regulatory precision. Missing information scored zero. A warning letter reduced the regulatory-precision score but did not erase good receipt evidence. The score measures paperwork friction only — not safety, medical quality, or effectiveness.

The formula, published

How partial credit works

• A provider that says only “FSA accepted” gets less than one that explains both direct payment and reimbursement.
• A self-service receipt earns more than “contact support.”
• LMN points require a public statement about what help is available. “Ask us questions” gets partial credit, not a guarantee.
• A clear monthly price earns more than a floor price spread across conflicting pages.
• A public cancellation cutoff earns more than “cancel anytime.”
• Naming a pharmacy or pharmacy partner earns more than saying only “U.S. pharmacy.”
• An FDA warning letter concerning the provider's compounded-drug marketing earns zero in the regulatory-precision factor until a verified close-out or later record supports a change.

The rules

• Missing information gets zero, not the benefit of the doubt.
• Provider-stated FSA eligibility is not treated as plan approval.
• A warning letter is a marketing or labeling signal, not a safety verdict on a patient's prescription.
• The score never overrides clinical eligibility, state availability, pharmacy checks, or your plan's decision.
• A hard document failure can override a numeric score. Yucca's refusal to provide receipts or LMNs disqualifies it for readers who may need substantiation.

What we deliberately did not count

Affiliate payout. Several caution-lane providers can pay more than the lead options. They remain in caution. Patiently does not pay us and is still included. Yucca is on our broader commercial roster and is still excluded for this job.

Review volume alone. A large review count can reflect advertising volume as much as satisfaction.

Brand recognition. A household name did not erase a warning letter or missing document policy.

Weight-loss results. We do not score them. A comparison page cannot tell you what your body will do.

Our conflicts, stated plainly

Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth services. We earn a commission when readers sign up through some links. Commercial relationships affect which providers we can link to. They do not change the evidence labels, warning-letter register, score formula, or the negative facts we publish.

Where we could not verify something, we wrote “not published” or “conflicting” instead of filling the gap.

📊 Download the full dataset (CSV, version 2026-08-15) — 22 fields covering payment path, receipt support, prices, commitment, cancellation, regulatory record, score, sources, and verification date.

Frequently asked questions

Can I use my FSA for compounded semaglutide?

Often, yes, when a licensed clinician prescribes it to treat a diagnosed disease and your plan accepts the documentation. IRS guidance says a weight-loss program can qualify when it treats a disease such as obesity, diabetes, hypertension, or heart disease. Compounded status does not automatically disqualify the expense. Your plan makes the claim decision.

Can I use my FSA for compounded tirzepatide?

The same rule applies. The prescription, medical purpose, lawful dispensing path, expense timing, and plan documents matter. The FSA card working or failing is not the final answer.

Which compounded GLP-1 providers take an FSA card at checkout?

As of August 15, 2026, Shed, Embody, Willow, IVY RX, Direct Meds, Ivim, MEDVi, SkinnyRX, Eden, and Maximus state that HSA or FSA cards can be used. Patiently is sold through FSA Store but says eligibility varies by plan. MyStart says some cards work and offers a reimbursement fallback. Hers recommends paying with a regular card and downloading a receipt. Ro says it does not accept HSA/FSA cards but provides a detailed receipt.

Which provider gives the best FSA receipt?

Shed has the best overall public receipt guidance because it publishes the portal path and separates program line items. IVY RX says it sends an itemized receipt immediately. MyStart publishes a full reimbursement packet. Hers lets members download a receipt from the Orders area. A strong receipt is not the same as guaranteed claim approval.

Do I need a letter of medical necessity for a GLP-1?

Not for every claim. A plan may request one when the charge is for a weight-management program, the receipt is vague, or the medical purpose is not clear. Ask the administrator before buying. Do not rely on a provider saying “FSA eligible” as proof that no LMN will be needed.

Who writes the letter of medical necessity?

Your treating clinician. You cannot write or approve it yourself, and a comparison website cannot issue one. Ask whether the provider's clinician will supply it, what information the plan needs, and whether there is a fee.

Why did my FSA card decline?

Common causes include merchant coding, card limits, account status, or a checkout that cannot automatically substantiate the purchase. Pay another way only when you can cover the charge, then submit the itemized receipt and requested documents. An accepted charge can still be reviewed later.

Does my FSA cover the membership fee, or only the medication?

Prescription medication for a diagnosed condition is the clearest part of the claim. Clinical visits and a medically necessary weight-management program may also qualify. General wellness, coaching, or supplements can be treated differently. Ask for a receipt that identifies each part.

Can I prepay a 6- or 12-month plan with my FSA?

Maybe, but ask first. FSAFEDS requires service dates rather than only the payment date, and its claim form asks you to certify that you already received the products or services. Your employer plan decides how it treats later medication shipments or services. Get that timing rule in writing before a large prepay.

What is the 2026 FSA contribution limit?

The health FSA salary-reduction limit is $3,400 for plan years beginning in 2026. A plan that permits carryover can allow up to $680 into the next plan year. Your employer decides whether its plan offers carryover.

What are the 2026 HSA limits?

The 2026 HSA contribution limits are $4,400 for self-only coverage and $8,750 for family coverage. HSA balances carry forward until used.

What if my receipt only says “weight loss program”?

Ask the provider for a corrected itemized receipt that shows the patient, provider or merchant, service or purchase date, actual prescription or service description, and amount. Do not alter the receipt yourself.

Does my FSA card working mean the medication is FDA-approved?

No. Payment processing and FDA approval are unrelated. Compounded semaglutide and tirzepatide are not FDA-approved.

What happens if I cannot substantiate a card charge?

Your plan may suspend the card and require repayment or another correction under its procedures. Read the notice, provide the requested records by the deadline, and keep the final decision.

Can I use my FSA and HSA together?

You may be able to spend existing HSA funds while you also have an FSA, but a general-purpose health FSA usually makes you ineligible to contribute new money to an HSA. Limited-purpose and post-deductible FSAs can work differently. Check Publication 969 and your plan documents before contributing.

Is Weight Loss Provider Guide a medical provider?

No. Weight Loss Provider Guide is an independent comparison resource. We do not prescribe medication, issue LMNs, dispense drugs, or process FSA claims. We verify public policies and primary regulatory sources, then publish what we find.

Still not sure which GLP-1 program is right for you?

Take our free 60-second matching quiz.

Your state, your plan's document rules, your deadline, your budget, and whether you want compounded or FDA-approved medication all change the answer. If you would rather not work it out from the table, the quiz gets you to the right lane faster.

No email required to see your results.

→ Get my personalized GLP-1 action plan

Already know what you want?

• Check Shed's live total and FSA options — best public documentation
• See Embody's current plan total — best current monthly price
• Compare Ro's FDA-approved path — insurance and prior-authorization help; medication costs extra

Sources

Government and primary sources

• IRS Publication 502, Medical and Dental Expenses — prescribed medicines, weight-loss treatment, illegal treatments, foreign drugs, and future-care discussion
• IRS medical-expense FAQ for nutrition, wellness, and general health — disease-treatment test for weight-loss programs
• IRS 2026 inflation adjustments — $3,400 health FSA cap and $680 carryover maximum
• IRS Publication 969 — HSA, FSA, and HRA rules
• IRS Revenue Procedure 2025-19 — 2026 HSA contribution limits
• FSAFEDS claim guidance — five receipt fields and unacceptable proof examples
• FSAFEDS health-care claim form — service dates, not payment date
• HealthEquity FSA card guidance — decline and reimbursement path; accepted charges may still need verification
• FDA's concerns with unapproved GLP-1 drugs
• FDA clarification after the semaglutide and tirzepatide shortages
• FDA 503B bulks-list proposal
• FDA dosing-error alert for compounded semaglutide
• FDA Foundayo approval announcement
• FDA warning letters linked in the caution register above

Provider sources checked August 15, 2026

• Shed FSA/HSA help center
• Shed current GLP-1 landing page
• Shed cancellation language
• Embody homepage
• Embody terms
• Willow FAQ
• Willow semaglutide-vs.-tirzepatide pricing
• IVY RX personalized GLP-1 page
• Direct Meds how it works
• Patiently through FSA Store
• Yucca FAQ
• Ivim pricing
• MEDVi program page
• MEDVi cancellation and refund policy
• Eden GLP-1 treatment pricing
• Maximus weight-loss program
• MyStart FSA/HSA document page
• Hers FSA/HSA reimbursement page
• Ro cost and services FAQ
• Ro Body pricing
• Sesame online weight-loss program

About this guide. Weight Loss Provider Guide is an independent comparison resource for GLP-1 telehealth services. We verify pricing, payment workflows, documentation, and regulatory standing on a scheduled cadence and publish what we find — including when a high-paying or famous provider has the bigger problem. Rankings are set by evidence and fit, in that order. Spot a price, policy, source, or warning-letter status we missed? Email editorial@weightlossproviderguide.com. We will review the correction and update the visible verification date only when the page is actually rechecked.

Medical, tax, and legal disclaimer. This guide is for information only. It is not medical, tax, legal, insurance, or benefits-plan advice. Talk with a licensed clinician before starting or changing medication. Confirm FSA eligibility, documentation, and expense timing with your plan administrator before paying. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Semaglutide, tirzepatide, and other GLP-1 medicines can cause side effects, and FDA-approved versions carry product-specific warnings and contraindications. Read the prescribing information for the exact product you are prescribed, tell the clinician your full medical and family history, and get urgent medical help for severe or concerning symptoms.